Plasma endothelin in NIDDM patients with and without complications

Diabetes Care. 1994 Jun;17(6):574-7. doi: 10.2337/diacare.17.6.574.

Abstract

Objective: To measure plasma endothelin 1 (ET-1) levels in uncomplicated non-insulin-dependent diabetes mellitus (NIDDM) and investigate whether ET levels may be related to angiopathy, blood pressure, metabolic control, or duration of illness.

Research design and methods: Plasma levels of ET-1 were measured in 44 NIDDM patients, of whom 24 had uncomplicated diabetes, 20 had angiopathy, and 10 had hypertension. In 21 patients, the duration of illness was > 10 years, and in 23 the duration of illness was < 10 years. Serum creatinine levels, microalbuminuria, and HbA1c were determined simultaneously. Thirty normotensive healthy (nondiabetic) individuals (20 men and 10 women) served as control subjects.

Results: No significant statistical differences in plasma ET-1 levels were found among all diabetic patients, diabetic patients with and without angiopathy, diabetic patients with different durations of diabetes, and normal subjects. No significant correlation of plasma ET-1 with blood pressure, age, serum creatinine level, duration of diabetes, HbA1c, or diabetic complications was found.

Conclusions: Plasma ET-1 levels are similar in patients with NIDDM and healthy subjects and do not seem to act as a marker of diabetic complications.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Albuminuria
  • Blood Pressure
  • Creatinine / blood
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetes Mellitus, Type 2 / urine
  • Diabetic Angiopathies / blood*
  • Diabetic Angiopathies / physiopathology
  • Diabetic Angiopathies / urine
  • Endothelins / blood*
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypertension / blood*
  • Hypertension / physiopathology
  • Male
  • Middle Aged
  • Reference Values
  • Time Factors

Substances

  • Endothelins
  • Glycated Hemoglobin A
  • Creatinine